Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Tri Locum Partners LP Stock Portfolio

$395Million– No. of Holdings #25

Tri Locum Partners LP Performance:
2024 Q2: 8.18%YTD: 25.66%2023: 17.97%

Performance for 2024 Q2 is 8.18%, and YTD is 25.66%, and 2023 is 17.97%.

About Tri Locum Partners LP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Tri Locum Partners LP reported an equity portfolio of $395.5 Millions as of 30 Jun, 2024.

The top stock holdings of Tri Locum Partners LP are TEVA, , . The fund has invested 10.5% of it's portfolio in TEVA PHARMACEUTICAL INDS LTD and 8.1% of portfolio in ARGENX SE.

The fund managers got completely rid off SILK RD MED INC (SILK), MERCK & CO INC (MRK) and VERTEX PHARMACEUTICALS INC (VRTX) stocks. They significantly reduced their stock positions in XENON PHARMACEUTICALS INC (XENE) and PRAXIS PRECISION MEDICINES I (PRAX). Tri Locum Partners LP opened new stock positions in AMGEN INC (AMGN), INSMED INC (INSM) and PFIZER INC (PFE). The fund showed a lot of confidence in some stocks as they added substantially to INSPIRE MED SYS INC (INSP), AXSOME THERAPEUTICS INC (AXSM) and ARGENX SE.
Tri Locum Partners LP Equity Portfolio Value
Last Reported on: 14 Aug, 2024

Tri Locum Partners LP Annual Return Estimates Vs S&P 500

Our best estimate is that Tri Locum Partners LP made a return of 8.18% in the last quarter. In trailing 12 months, it's portfolio return was 44.72%.

New Buys

Ticker$ Bought
amgen inc25,705,600
insmed inc21,205,600
pfizer inc16,701,800
united therapeutics corp del15,959,400
alnylam pharmaceuticals inc10,935,000
stevanato group s p a10,369,800
novo-nordisk a s9,108,380
vaxcyte inc8,558,600

New stocks bought by Tri Locum Partners LP

Additions

Ticker% Inc.
inspire med sys inc465
axsome therapeutics inc198
argenx se166
regeneron pharmaceuticals104
ascendis pharma a/s102
legend biotech corp25.64
madrigal pharmaceuticals inc22.49
natera inc21.29

Additions to existing portfolio by Tri Locum Partners LP

Reductions

Ticker% Reduced
xenon pharmaceuticals inc-50.85
praxis precision medicines i-29.27

Tri Locum Partners LP reduced stake in above stock

Sold off

Ticker$ Sold
silk rd med inc-19,851,600
lyra therapeutics inc-6,088,090
perspective therapeutics inc-928,561
arcutis biotherapeutics inc-4,456,470
astria therapeutics inc-5,201,400
tandem diabetes care inc-11,561,600
baxter intl inc-13,572,800
arcturus therapeutics hldgs-4,691,560

Tri Locum Partners LP got rid off the above stocks

Sector Distribution

Tri Locum Partners LP has about 74.5% of it's holdings in Healthcare sector.

Sector%
Healthcare74.5
Others25.5

Market Cap. Distribution

Tri Locum Partners LP has about 44.3% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
LARGE-CAP44.3
UNALLOCATED25.5
MID-CAP23.6
SMALL-CAP6.6

Stocks belong to which Index?

About 34.7% of the stocks held by Tri Locum Partners LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others65.3
RUSSELL 200019.3
S&P 50015.4
Top 5 Winners (%)%
INSM
insmed inc
151.9 %
ALNY
alnylam pharmaceuticals inc
62.1 %
MRUS
merus n v
30.7 %
UTHR
united therapeutics corp del
18.7 %
OCUL
ocular therapeutix inc
18.4 %
Top 5 Winners ($)$
INSM
insmed inc
12.8 M
TEVA
teva pharmaceutical inds ltd
4.7 M
MRUS
merus n v
4.7 M
ALNY
alnylam pharmaceuticals inc
4.2 M
NTRA
natera inc
3.3 M
Top 5 Losers (%)%
PRAX
praxis precision medicines i
-29.4 %
FEMY
femasys inc
-26.4 %
INSP
inspire med sys inc
-23.9 %
MNMD
mind medicine mindmed inc
-23.3 %
AVDL
avadel pharmaceuticals plc
-16.8 %
Top 5 Losers ($)$
INSP
inspire med sys inc
-5.6 M
AVDL
avadel pharmaceuticals plc
-3.4 M
PRAX
praxis precision medicines i
-1.9 M
MNMD
mind medicine mindmed inc
-0.8 M
XENE
xenon pharmaceuticals inc
-0.8 M

Tri Locum Partners LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Tri Locum Partners LP

Tri Locum Partners LP has 25 stocks in it's portfolio. About 65.2% of the portfolio is in top 10 stocks. INSP proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for Tri Locum Partners LP last quarter.

Last Reported on: 14 Aug, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions